Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: A case report and review of the literature

Cutaneous and Ocular Toxicology

Volumn 30, Issue 2, 2011, Pages 147-153

  Morais, Paulo ^a,b   Baudrier, Teresa ^a   Mota, Alberto ^a,b   Cunha, Ana Paula ^a   Alves, Marta ^a   Neves, Celestino ^a,b   Capela, João ^a   Sá Couto, Pedro ^a   Azevedo, Filomena ^a  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

ANCA; Antineutrophil cytoplasmic antibody; Graves' disease; leukocytoclastic vasculitis; propylthiouracil; skin patch tests

Indexed keywords

LEVOTHYROXINE SODIUM; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PETROLATUM; PREDNISOLONE; PROPYLTHIOURACIL; STEROID;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTICLE; ASTHENIA; BULLOUS SKIN DISEASE; CASE REPORT; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FEVER; FOLLOW UP; GRAVES DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOCYTOCLASTIC VASCULITIS; MALAISE; MYALGIA; PAPULAR SKIN DISEASE; PATCH TEST; REMISSION; SIDE EFFECT; SKIN ULCER; THYROIDECTOMY; WEIGHT REDUCTION;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTITHYROID AGENTS; FEMALE; GRAVES DISEASE; HUMANS; LETHAL DOSE 50; PROPYLTHIOURACIL; SKIN TESTS; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS;

EID: 79957487932     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2010.533318     Document Type: Article

References (43)

1. Jennette, J.C., Falk, R.J. Small-vessel vasculitis. N. Engl. J. Med. 1997, 337, 1512-1523. (Pubitemid 27495778)
2. Carlson, J.A., Cavaliere, L.F., Grant-Kels, J.M. Cutaneous vasculitis: diagnosis and management. Clin. Dermatol. 2006, 24, 414-429. (Pubitemid 44332870)
3. Choi, H.K., Merkel, P.A., Walker, A.M., Niles, J.L. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000, 43, 405-413. (Pubitemid 30395751)
4. Savige, J., Davies, D., Falk, R.J., Jennette, J.C., Wiik, A. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int. 2000, 57, 846-862. (Pubitemid 30434775)
5. Cooper, D.S. Antithyroid drugs. N. Engl. J. Med. 2005, 352, 905-917. (Pubitemid 40300299)
6. Ye, Y.M., Kim, J.E., Kim, J.H., Choi, G.S., Park, H.S. Propylthiouracilinduced DRESS syndrome confirmed by a positive patch test. Allergy 2010, 65, 407-409.
7. Seo, J.W., Son, H.H., Choi, J.H., Lee, S.K. A case of p-ANCApositive propylthiouracil-induced pyoderma gangrenosum. Ann. Dermatol. 2010, 22, 48-50.
8. Stankus, S.J., Johnson, N.T. Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest 1992, 102, 1595-1596.
9. Dolman, K.M., Gans, R.O., Vervaat, T.J., Zevenbergen, G., Maingay, D., Nikkels, R.E., Donker, A.J., von dem Borne, A.E., Goldschmeding, R. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993, 342, 651-652. (Pubitemid 23271506)
10. Hachicha, M., Kammoun, T., Ben Romdhane, W., Ben Abdallah, R., Mahfoudh, A., Kammoun, K., Hachicha, J., Triki, A. [Vasculitis with renal involvement and antineutrophil cytoplasmic antibodies (ANCA) in a child receiving benzylthiouracil]. Nephrol. Ther. 2007, 3, 147-151. (Pubitemid 47069117)
11. Barbaud, A., Goñalo, M., Bruynzeel, D., Bircher, A.; European Society of Contact Dermatitis. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Derm. 2001, 45, 321-328. (Pubitemid 34056345)
12. Wilkinson, D.S., Fregert, S., Magnusson, B., Bandmann, H.J., Calnan, C.D., Cronin, E., Hjorth, N., Maibach, H.J., Malalten, K.E., Meneghini, C.L., Pirilä, V. Terminology of contact dermatitis. Acta Derm. Venereol. 1970, 50, 287-292.
13. Noh, J.Y., Asari, T., Hamada, N., Makino, F., Ishikawa, N., Abe, Y., Ito, K., Ito, K. Frequency of appearance of myeloperoxidaseantineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clin. Endocrinol. (Oxf) 2001, 54, 651-654. (Pubitemid 34208909)
14. Sato, H., Hattori, M., Fujieda, M., Sugihara, S., Inomata, H., Hoshi, M., Miyamoto, S. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. J. Clin. Endocrinol. Metab. 2000, 85, 4270-4273. (Pubitemid 32055385)
15. Yazisiz, V., Ongüt, G., Terzioglu, E., Karayal̃in, U. Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment. Int. J. Clin. Pract. 2010, 64, 19-24.
16. von Schmiedeberg, S., Goebel, C., Gleichmann, E., Uetrecht, J. Neutrophils and drug metabolism. Science 1995, 268, 585-586.
17. Jiang, X., Khursigara, G., Rubin, R.L. Transformation of lupusinducing drugs to cytotoxic products by activated neutrophils. Science 1994, 266, 810-813. (Pubitemid 24359291)
18. Cambridge, G., Wallace, H., Bernstein, R.M., Leaker, B. Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br. J. Rheumatol. 1994, 33, 109-114. (Pubitemid 24051599)
19. Lee, E., Miki, Y., Katsura, H., Kariya, K. Mechanism of inactivation of myeloperoxidase by propylthiouracil. Biochem. Pharmacol. 1990, 39, 1467-1471. (Pubitemid 20122584)
20. Yu, F., Zhao, M.H., Zhang, Y.K., Zhang, Y., Wang, H.Y. Antiendothelial cell antibodies (AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity. Clin. Exp. Immunol. 2005, 139, 569-574. (Pubitemid 40333269)
21. Ye, H., Gao, Y., Guo, X.H., Zhao, M.H. Titre and affinity of propylthiouracil-induced anti-myeloperoxidase antibodies are closely associated with the development of clinical vasculitis. Clin. Exp. Immunol. 2005, 142, 116-119. (Pubitemid 41361013)
22. Gao, Y., Chen, M., Ye, H., Guo, X.H., Zhao, M.H., Wang, H.Y. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis. Clin. Endocrinol. (Oxf ) 2007, 66, 543-547. (Pubitemid 46434937)
23. Gao, Y., Chen, M., Ye, H., Yu, F., Guo, X.H., Zhao, M.H. Longterm outcomes of patients with propylthiouracil-induced antineutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatology (Oxford). 2008, 47, 1515-1520.
24. Gunton, J.E., Stiel, J., Caterson, R.J., McElduff, A. Clinical case seminar: anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature. J. Clin. Endocrinol. Metab. 1999, 84, 13-16. (Pubitemid 29036673)
25. Gao, Y., Zhao, M.H., Guo, X.H., Xin, G., Gao, Y., Wang, H.Y. The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism. Endocr. Res. 2004, 30, 205-213. (Pubitemid 39243121)
26. Lionaki, S., Hogan, S.L., Falk, R.J., Joy, M.S., Chin, H., Jennette, C.E., Jennette, J.C., Nachman, P.H. Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study. Nephrol. Dial. Transplant. 2007, 22, 3508-3515. (Pubitemid 350212510)
27. Batchelor, N., Holley, A. A fatal case of propylthiouracil-induced ANCA-positive vasculitis. MedGenMed 2006, 8, 10.
28. Stein, J.C., Hernandez, S., Hebig, A. Necrotizing vasculitis as a complication of propylthiouracil. West. J. Emerg. Med. 2008, 9, 212-215.
29. Chen, Y.X., Yu, H.J., Ni, L.Y., Zhang, W., Xu, Y.W., Ren, H., Chen, X.N., Wang, X.L., Li, X., Pan, X.X., Wang, W.M., Chen, N. Propylthiouracilassociated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases. J. Rheumatol. 2007, 34, 2451-2456. (Pubitemid 350230670)
30. Jennette, J.C., Xiao, H., Falk, R.J. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. J. Am. Soc. Nephrol. 2006, 17, 1235-1242. (Pubitemid 43673403)
31. Gao, Y., Chen, M., Ye, H., Guo, X.H., Zhao, M.H., Wang, H.Y. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil. Int. Immunopharmacol. 2007, 7, 55-60. (Pubitemid 44856387)
32. Bonaci-Nikolic, B., Nikolic, M.M., Andrejevic, S., Zoric, S., Bukilica, M. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res. Ther. 2005, 7, R1072-R1081.
33. ten Holder, S.M., Joy, M.S., Falk, R.J. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann. Pharmacother. 2002, 36, 130-147. (Pubitemid 34055784)
34. Noh, J.Y., Yasuda, S., Sato, S., Matsumoto, M., Kunii, Y., Noguchi, Y., Mukasa, K., Ito, K., Ito, K., Sugiyama, O., Kobayashi, H., Nihojima, S., Okazaki, M., Yokoyama, S. Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J. Clin. Endocrinol. Metab. 2009, 94, 2806-2811.
35. Fujieda, M., Hattori, M., Kurayama, H., Koitabashi, Y.; Members and Coworkers of the Japanese Society for Pediatric Nephrology. Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J. Am. Soc. Nephrol. 2002, 13, 437-445. (Pubitemid 34106286)
36. Quax, R.A., Swaak, A.J., Baggen, M.G. Churg-Strauss syndrome following PTU treatment. Int. J. Rheumatol. 2009, 2009, 504105.
37. Zhao, M.H., Chen, M., Gao, Y., Wang, H.Y. Propylthiouracilinduced anti-neutrophil cytoplasmic antibody-associated vasculitis. Kidney Int. 2006, 69, 1477-1481.
38. Hogan, S.L., Falk, R.J., Chin, H., Cai, J., Jennette, C.E., Jennette, J.C., Nachman, P.H. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann. Intern. Med. 2005, 143, 621-631.
39. Ishii, R., Imaizumi, M., Ide, A., Sera, N., Ueki, I., Horie, I., Ando, T., Usa, T., Ejima, E., Ashizawa, K., Eguchi, K. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil. Endocr. J. 2010, 57, 73-79.
40. Gao, Y., Ye, H., Yu, F., Guo, X.H., Zhao, M.H. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis. Clin. Immunol. 2005, 117, 87-93. (Pubitemid 41725474)
41. Ahmed, K., Rao, S., Simha, V. Antineutrophil cytoplasmic antibodypositive vasculitis in a patient with graves disease: cross-reaction between propylthiouracil and methimazole. Endocr. Pract. 2010, 16, 449-451.
42. Peters, H., Fischer, C., Bogner, U., Reiners, C., Schleusener, H. Treatment of Graves' hyperthyroidism with radioiodine: results of a prospective randomized study. Thyroid 1997, 7, 247-251. (Pubitemid 27190591)
43. Stone, O.J. Proliferative iododerma. A possible mechanism. Int. J. Dermatol. 1985, 24, 565-566. (Pubitemid 16230347)